In the latest issue of “Świat Przemysłu Farmaceutycznego,” an article by attorney-at-law Joanna Uchańska, partner at AJ LAW Uchańska Diskau, entitled “Rap, Prescriptions and Legal Provisions: Can Literary Interpretation Defend Itself Before the Chief Pharmaceutical Inspector and What Does It Have to Do with Pharmaceutical Advertising?” has been published. The article is devoted to one of the most widely discussed decisions of the Chief Pharmaceutical Inspector in recent months and its potential consequences for the pharmaceutical market and contemporary marketing communication.
The case concerns a decision issued by the Chief Pharmaceutical Inspector on April 2, 2026, in which the authority concluded that the work of one of Poland’s most popular rappers – Taco Hemingway – may exceed the limits of artistic freedom and constitute unlawful advertising of a medicinal product containing codeine. This precedent-setting decision opens a debate not only on the boundaries of pharmaceutical law, but also on the methods of interpreting cultural and artistic messages by public administration authorities.
The article addresses, among others, the following issues:
• The limits of artistic freedom in light of pharmaceutical law regulations
• An analysis of the Chief Pharmaceutical Inspector’s decision of April 2, 2026, and its reasoning
• The definition of medicinal product advertising and its practical interpretation
• Legal risks associated with non-standard forms of communication
• The impact of the decision on marketing and educational campaigns in the pharmaceutical industry
• Challenges related to the interpretation of messages based on emotions, narrative, and artistic creativity
• The future of digital communication in the context of dynamically evolving forms of expression
• The significance of the decision for businesses operating in the pharmaceutical market
We invite you to read the article!
For more information, please contact Attorney-at-law Joanna Uchańska at: juchanska@ajlaw.pl.